R-roscovitine
R-roscovitine Uses, Dosage, Side Effects, Food Interaction and all others data.
R-roscovitine (R-roscovitine or CYC202) is a cyclin-dependent kinase (CDK) inhibitor that preferentially inhibits multiple enzyme targets including CDK2, CDK7 and CDK9, which alter the growth phase of treated cells. Developed by Cyclacel, seliciclib is being researched for the treatment of non-small cell lung cancer (NSCLC), leukemia, HIV infection, herpes simplex infection, and the mechanisms of chronic inflammation disorders.
| Trade Name | R-roscovitine |
| Generic | Seliciclib |
| Seliciclib Other Names | R-roscovitine, Seliciclib |
| Type | |
| Formula | C19H26N6O |
| Weight | Average: 354.4493 Monoisotopic: 354.216809484 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Uses
Investigated for use/treatment in breast cancer, lung cancer, lymphoma (unspecified), multiple myeloma, leukemia (lymphoid), and cancer/tumors (unspecified).
Innovators Monograph
You find simplified version here R-roscovitine
